News

Landis+Gyr Unveils Growth Strategy at CMD 2026

Landis+Gyr Unveils Growth Strategy at CMD 2026

Strategic Shifts on the Horizon

You've got a major player like Landis+Gyr setting their sights on the energy tech landscape, and it's hard not to take notice. Throwing their fishing line way past 2028, they're banking on big returns—not just wishes and sky-high dreams. They’re out here at Nasdaq's MarketSite in New York, flexing their plans and spitting numbers that might just change the game.

New Business Segments in the Works

Forget what you knew about Landis+Gyr; they’re rolling out new segments with fancy names: Connected Platforms and Grid Intelligence. Sounds sleek, right? These fresh faces are the gears that’ll drive home growth and innovation. They’re gearing up to capitalize on a transforming energy landscape—and if they're half as good as they say, we're in for a show.

Steady Momentum Across Core Technologies

Talking about momentum, they've got it in spades. Revelo® and Surent™ platforms are tearing it up, along with a host of techs that sound like alphabet soup—AI this, analytics that. Expect to see development in intelligent gas and flexibility management too. The numbers they're touting—$3.9 billion in backlog—aren’t exactly peanuts either.

"With the introduction of our new business segments, we are well positioned to capitalize on significant growth opportunities across the evolving energy landscape." - Peter Mainz, CEO

Mid-term Outlook Aims High

Every ship’s gotta have a heading: for Landis+Gyr, it's all about getting specific. By 2028, they're eyeing a mid-single-digit revenue CAGR, with gross margins over 35%, and adjusted EPS growing more than five times the rate of revenue. Talk about seeing things through rose-colored glasses—or maybe just glasses full of opportunity.

  • Mid-single-digit revenue CAGR through FY 2028
  • Gross margin >35%
  • Adjusted EBITDA CAGR twice the revenue rate
  • Free Cash Flow conversion of roughly 80% from Adjusted EBITDA

Looking Ahead with Financial Stability

Balancing the books, their asset-light model seems to be their biggest bragging right. ROIC sitting pretty above 30% and a solid balance sheet. If you're nursing dreams of strategic flexibility, here's your cup of coffee. If we believe the talk, they're up to something big, and don’t mind letting the numbers do the talking.

The Final Bet

With $4 billion in backlog, a little confidence in the market seems justified. They're sizing up massive opportunities with broad strokes and detailed foresight. For investors, the playbook might not be completely laid out, but the outlines look promising. It's not bullish beyond belief nor overly conservative; it's a tightrope that more seasoned players might be eyeing closely.

The bottom line is, Landis+Gyr's financial frameworks and business realignment could pave the way for something exceptional. A mix of strategic foresight and operational discipline might just fortify this enterprise's hold on the market. Keep your eyes peeled; this energy tech leader could be rewriting some rules as we speak.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 33

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 32

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 32

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breast Suite Transforming Cancer Detection and Care

Updated Category News Views 118

Introducing the AI-Driven DeepHealth Breast Suite DeepHealth has recently launched its Breast Suite, a revolutionary set of AI-powered applications that significantly boosts the effectiveness of breast cancer detection and patient care. This suite is part of a broader initiative to improve health informatics and operational efficiency, showcasing DeepHealth's commitment...

Continue Reading
AVATR Unveils Innovative Luxury Electric Vehicle in Munich

Updated Category News Views 193

AVATR Unveils Innovative Luxury Electric Vehicle in Munich At the recent "Brilliant New Horizon AVATR Brand Day" event, the President of AVATR Technology, Mr. Chen Zhuo, shared insights about the brand's identity. He explained that AVATR transcends the typical electric vehicle company image by embracing high-end sophistication, intelligence, and design. Emotional...

Continue Reading
Security Federal Corporation Expands Stock Repurchase Program

Updated Category News Views 128

Security Federal Corporation Unveils New Stock Repurchase Program Security Federal Corporation (the “Company”) (OTCBB: SFDL), which serves as the holding company for Security Federal Bank (the “Bank”), has recently announced an increase in the number of shares it is authorized to repurchase under its existing stock repurchase program. This updated initiative...

Continue Reading
Experience 'Hot Fellas' Bakery: Immersive NYC Event Awaits

Updated Category News Views 379

Unveiling the Hot Fellas Bakery Pop-Up Experience in NYC The beloved storyline of the Max Original series "And Just Like That…" springs to life with an exciting two-day immersive pop-up event. Fans will have the unique opportunity to step into Anthony Marentino's famous 'Hot Fellas' Bakery, inviting them to participate in a fun and delicious experience. Details of the...

Continue Reading
EyePoint Pharmaceuticals Pursues Major Stock Offering for Growth

Updated Category News Views 228

EyePoint Pharmaceuticals Pursues Major Stock Offering EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leader in developing innovative therapies for patients suffering from serious retinal diseases, has taken a significant step toward advancing its initiatives by announcing a proposed underwritten public offering. The company is set to offer $150 million of its common...

Continue Reading